✦ LIBER ✦

Neoadjuvant Therapy for Achieving Margin Negative Resection in Borderline Resectable Pancreatic Ductal Adenocarcinoma

✍ Scribed by Chandrasekaran, S.; Coveler, A.L.; Chandrasekaran, S.; Lucas, F.R.; Patel, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant therapy for resectable and b

✍ Kumar, Rachit; Jabbour, Salma K. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 348 KB

Induction gemcitabine-based chemotherapy

✍ Michael D. Chuong, Gregory M. Springett, Jill Weber… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 306 KB

Potential Contribution of Preoperative N

✍ Chang Moo Kang; Yong Eun Chung; Jeong Youp Park; Jin Sil Sung; Ho Kyoung Hwang; 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Immunological Impact of Neoadjuvant Chem

✍ Homma, Yuki; Taniguchi, Koichi; Murakami, Takashi; Nakagawa, Kazuya; Nakazawa, M 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 375 KB

515 Single Institution Experience With N

✍ Bolton, Nathan; Conway, William C.; Bolton, John S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Prognostic factors in resections for pan

✍ Coe, Peter; Kausar, Ambareen; de Liguori Carino, Nicola; Deshpande, Rahul; Ammor 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 42 KB